FTC challenges around 100 FDA Orange Book patent listings | Hogan Lovells
The U.S. Federal Trade Commission (FTC) announced that it issued warning letters to 10 drug manufacturers and challenged the Orange Book listings for around 100 patents under the U.S....
Source: jdsupra.com